Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Assets    
Financing receivables $ 804,005 $ 783,967
Financing receivables held-for-sale 42,285 60,376
Investments available-for-sale 47,662 29,017
Real estate 131,713 128,769
Real estate related intangible assets 30,720 26,930
Equity method investments in affiliates 334,565 318,769
Cash and cash equivalents 19,279 42,645
Other assets 65,909 79,148
Total Assets 1,476,138 1,469,621
Liabilities:    
Accounts payable, accrued expenses and other 26,165 17,875
Deferred funding obligations 78,127 108,499
Credit facility 245,572 247,350
Nonrecourse debt (secured by assets of $779 million and $815 million, respectively) 624,043 663,791
Total Liabilities 973,907 1,037,515
Stockholders' Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 41,985,976 and 37,010,603 shares issued and outstanding, respectively 420 370
Additional paid in capital 576,041 482,431
Retained deficit (71,200) (52,701)
Accumulated other comprehensive loss (6,821) (1,905)
Non-controlling interest 3,791 3,911
Total Stockholders' Equity 502,231 432,106
Total Liabilities and Stockholders' Equity $ 1,476,138 $ 1,469,621